10.77 -0.23 (-2.24%)
OSUR
| Trade OSUR now with |
Stock Details
Last Trade:10.77 Change:-0.23 (-2.24%) Prev Close:11.00 Open: 10.25 Days Range:10.00 – 11.15 52 Week Range: 6.18 - 11.78 Volume:764534 P/E: N/AEPS:-0.22
View AllRecent Alerts 02/09/12
Recent Alert on 02/09/12 at 11:14am
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $14.00. Analyst, Jeffrey Frelick, said, "While still mostly a catalyst story, quarterly results were in line to slightly ahead of expectations. The Q1/12... Read More
Recent Alert on 02/09/12 at 11:14am
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Recent Alert on 02/09/12 at 11:14am
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Canaccord Genuity Reiterates a 'Buy' on OraSure Technologies (OSUR); Catalysts on the Horizon
Recent Alert on 02/09/12 at 8:52am
McNicoll Lewis & Vlak Downgrades OraSure Technologies (OSUR) to Hold
McNicoll Lewis & Vlak Downgrades OraSure Technologies (OSUR) to Hold
Recent Alert on 02/08/12 at 4:21pm
OraSure Technologies, Inc. (OSUR) Tops Q4 EPS by 5c, Offers Weak Q1 Guidance
OraSure Technologies, Inc. (OSUR) Tops Q4 EPS by 5c, Offers Weak Q1 Guidance
View AllRecent Press Releases
Press Release on 02/08/12 at 4:00pm
OraSure Announces Fourth Quarter and Full-Year 2011 Financial Results
OraSure Announces Fourth Quarter and Full-Year 2011 Financial Results
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 01/07/11 at 8:22am
OraSureTechnologies: A Biotech Company Poised to Revolutionize Two Markets
OraSureTechnologies: A Biotech Company Poised to Revolutionize Two Markets
Blog Posts on 09/25/09 at 4:23am
BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte
BioMed News Bytes: Dendreon, Chelsea, Cytori, Cephalon, OraSure, Genzyme, Lixte


